AVR 2.97% $12.15 anteris technologies ltd

Ann: Extension of Voluntary Suspension, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,577 Posts.
    lightbulb Created with Sketch. 162
    With our new TAVR product looking like it could fill an important part , by providing what looks like 'best in class' at the present, a TAVR that the seven Leading US clinicians from High Profile Centres, seem to think is a Great product.
    They've been working closely with Admedus from what I understand, is partly because of the quality of what they've seen.
    Since they've been involved in assisting AHZ with helping to produce something that top Cardio surgeons would love to have to work with.
    Just maybe they have connections with people with BIG pockets,that may be interested in putting money into the company.
    From working with the AHZ people behind this new TAVR and building up a possible huge amount of respect, wouldn't like to see this get taken over by one of the top Med companies
    What else have AHZ got in the pipeline that they have been privy to as well?
    To put something together most probably takes quite some time to make sure all parties are happy with the deal .
    Admedus's IP is leading edge (especially 3D & TAVR )....Leading edge doesn't come cheap.

    As I aid previously may be 4C could like a piece of the action.

    I'm still hopeful of a good out come.

    Regards
    Dabru
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.